Evaluation of a Health Literacy Intervention on Patients Suffering From Hypertension in Primary Care
NCT ID: NCT07015463
Last Updated: 2025-07-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
255 participants
INTERVENTIONAL
2025-07-31
2028-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Health Literacy-Focused Program to Improve Blood Pressure Control in Korean Americans
NCT00406614
Enhancing the Risk Assessment and Management Program by Promotion of Self-blood Pressure Monitoring
NCT02551393
Study to Improve Quality of Care and Patient Health in the Field of Cardiovascular Risk Factors in General Practice
NCT00348855
Improving Care for Patients With High Blood Pressure
NCT01425515
Provider Skill Building for Engagement and Communication in Healthcare - Hypertension Management
NCT07147075
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The second phase of the study will be a mixed-method evaluation of the intervention's effectiveness. Initially, a cluster-randomized trial will be conducted. Thirty-six physicians will participate and randomized into either the control group or the intervention group. Each physician will recruit approximately 5 patients. Patients will undergo a pre-inclusion visit, an inclusion visit, and then three follow-up visits (at 3 and 6 months). Finally, all participating physicians and a subsample of 30 patients will take part in the qualitative study to assess the perceived effectiveness of the intervention.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
General Practitioner (GP) exposed to the intervention
The intervention will be developed during the first phase according to the theoretical conceptual model Health proposed by Bas Geboers. The final intervention will take the form of a standardized intervention guide containing the elements of the intervention.
Five targets respond to the theoretical model:
* Healthcare professionals, through interventions enabling them to improve their skills regarding health literacy (HL) (such as identifying HL problems in their patients, increasing their communication skills, etc.)..
* The patient and their entourage, through interventions that strengthen the support of their entourage (family, peers, etc.).
* Patients, through empowerment interventions.
* Patient-health system interaction, through interventions aimed at improving communication between patients and healthcare professionals.
* Improving blood pressure control access, through interventions focused on reducing access barriers or policies to improve the quality of care.
Multi-component intervention in health literacy
Multi-component intervention aiming at increasing the health literacy of patients suffering from hypertension, in achieving the target blood pressure goal three months after the start of the intervention in poorly controlled hypertensive patients
GP of the control group
GP following usual guidelines
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Multi-component intervention in health literacy
Multi-component intervention aiming at increasing the health literacy of patients suffering from hypertension, in achieving the target blood pressure goal three months after the start of the intervention in poorly controlled hypertensive patients
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
o In this phase, physicians and patient representatives from patient associations or recruited through physicians will be enrolled.
Phase 2: Evaluation of the Intervention's Effectiveness
General practitioners practicing:
* In individual offices, in non-multidisciplinary group practices
* Or in multidisciplinary health centers or health centers
* In Nice, Bordeaux, and Lille
* Who have expressed their non-opposition
* Willing to participate in the qualitative evaluation
* Adult French-speaking patients, able to read and write
* Suffering from essential uncontrolled and treated hypertension treated measured by home self-monitoring
* Owning a mobile phone (to be contacted for the study and to receive reminder by phone)
* Able to self-measure his/her blood pressure at home
* Who have expressed their non-opposition
Inclusion for qualitative interviews Only individuals from the intervention group will be asked to participate in these interviews.
* All physicians who recruited patients for the trial will be invited to participate.
* A subsample of 30 patients (10 per city), selected according to the principle of maximum variation (ensuring diversity in age and gender)
Exclusion Criteria
Phase 2: Evaluation of the effectiveness of the intervention
* GP who participated in the first phase of co-construction.
* GP from a health center where a collaborator has already been recruited for the study.
* GP working in collaboration with an Asalée nurse.
* Patient suffering from secondary hypertension.
* Patient with severe cognitive impairment or dementia.
* Patients already performing regular self-monitoring of their blood pressure.
* Healthcare professionals.
* Patient under legal protection, guardianship, or curatorship.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Bordeaux
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Florence FRANCIS-OLIVIERO, MD
Role: PRINCIPAL_INVESTIGATOR
IRDES
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHUBX 2023/53
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.